SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: RT who wrote (20668)4/16/1999 12:00:00 PM
From: Brasco One  Read Replies (2) | Respond to of 23519
 
VVUS is an all time money maker for shorts! i luv it!



To: RT who wrote (20668)4/16/1999 12:11:00 PM
From: VLAD  Read Replies (3) | Respond to of 23519
 
RT,

Let me try one more time......THERE IS TENS OF MILLIONS OF $$$$ BANKING ON VIVUS' DEMISE. The shorts mantra has been short on strength but as of lately it appears that each time they pound Vivus down, they are unable to drive it down as low as on the prior pullback.

IMO their time is running out. Just too many positives to be released through the course of Q2. As you well know:

1)Conference call April 21st
2)AUA meeting with good presentations from Vivus May 1 to 6.
3)Astra/Zeneca will announce their launch of MUSE in the European Union countries in May.
4)Spain approval for $2M milestone
5)Italy approval for $2M milestone
6)Viagra death rates still relatively swept under the rug but with Viagra out officially for one year now, a safety report is due VERY soon. Maybe they will give Viagra the LONG OVERDUE BLACK BOX LABELING!!!!
7)More info on R&D progress including Alibra, female SD product, gene therapy and more.
8)Probable Japan partner announcement..........AND

9)A DOMESTIC PARTNERSHIP SIGNED WITH ASTRAZENECA?????

The only reason anyone would short Vivus at these levels would be to break the spirit of the small investors who are holding over 3/4 of the shares and promote their short AGENDA!

Thank You very much.